funded at $1,075,165 to support several laboratories in Texas and Florida. BCD's portion of the funding is $120,325.Research will concentrate on the relationship
between molecular structure and biological activity (the anti-cancer activity linked to citrus limonoids). "In some ways, it is like a designer drug study," Miller said. "However, we are focusing on the prevention of
cancer, not cancer treatment." Miller also serves as a principal investigator at the BCD site. Co-investigator Dr. Samuel Taylor,
associate professor of oral and maxillofacial surgery/pharmacology and director of pharmacology, joins him. Other program directors include Dr. Bhimanagouda Patil at Texas A&M University-Kingsville and Dr. Jennifer Brodbelt at the University of Texas in Austin.
|
